Your browser doesn't support javascript.
loading
Study of the Efficacy of Uptitrating Teneligliptin Dose from Standard Dose (20 mg) to High Dose (40 mg) in Patients with Type II Diabetes Mellitus.
Panikar, Vijay; Joshi, Shashank; Tiwaskar, Mangesh; Bhondve, Amit; Nasikkar, Nikhil; Walawalkar, Sanhita; Sachdev, Ishita; Panikar, Krish; Modh, Khushbu; Kulkarni, Pallavi; Medidar, Rahul; Tuteja, Harshpreet; Mansoori, Sana.
Affiliation
  • Panikar V; Consultant, Lilavati Hospital & Research Centre.
  • Joshi S; Consultant, Lilavati Hospital & Research Centre.
  • Tiwaskar M; Consultant Physician and Diabetologist, Shilpa Medical Research Centre.
  • Bhondve A; Consultant, Dr Panikar's Speciality Care Centre.
  • Nasikkar N; Assistant Professor, KJ Somaiya Medical College and Research Centre.
  • Walawalkar S; Consultant, Dr Panikar's Speciality Care Centre.
  • Sachdev I; Student, Dr. Panikar's Speciality Care Centre; 9-13Student, Lilavati Hospital & Research Centre, Mumbai, Maharashtra, India.
  • Panikar K; Student, Dr. Panikar's Speciality Care Centre.
  • Modh K; Student, Lilavati Hospital & Research Centre, Mumbai, Maharashtra, India.
  • Kulkarni P; Student, Lilavati Hospital & Research Centre, Mumbai, Maharashtra, India.
  • Medidar R; Student, Lilavati Hospital & Research Centre, Mumbai, Maharashtra, India.
  • Tuteja H; Student, Lilavati Hospital & Research Centre, Mumbai, Maharashtra, India.
  • Mansoori S; Student, Lilavati Hospital & Research Centre, Mumbai, Maharashtra, India; Corresponding Author.
J Assoc Physicians India ; 70(7): 11-12, 2022 Jul.
Article in En | MEDLINE | ID: mdl-35833400
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors Type of study: Observational_studies Limits: Female / Humans / Male Language: En Journal: J Assoc Physicians India Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors Type of study: Observational_studies Limits: Female / Humans / Male Language: En Journal: J Assoc Physicians India Year: 2022 Type: Article